Literature DB >> 12196922

Prognostic significance of cyclooxygenase-2 pathway and angiogenesis in head and neck squamous cell carcinoma.

Oreste Gallo1, Emanuela Masini, Benedetta Bianchi, Luca Bruschini, Milena Paglierani, Alessandro Franchi.   

Abstract

Prostaglandins play a critical role in tumor development and growth by regulating numerous biologic processes, including tumor angiogenesis, with clear prognostic and therapeutic implications. The aim of this study was to investigate the prognostic relevance of cyclooxygenase-2 (COX-2) pathway activation in head and neck squamous cell carcinoma (HNSCC). COX-2 activity was analyzed in 52 consecutive patients by assessing protein expression and prostaglandin E(2) (PgE(2)) levels and was then correlated to vascular endothelial growth factor (VEGF) expression and tumor angiogenesis. We evaluated the prognostic impact of these parameters by Kaplan-Meier and Cox survival analysis. COX-2 expression by tumor cells was closely correlated to VEGF expression and to tumor vascularization. According to Kaplan-Meier analysis, patients with COX-2 tumor overexpression and with higher PgE(2) tumor levels had significantly shorter overall survival estimates (P = 0.022 and P = 0.033, respectively). Analogously, patients with more-vascularized tumors had worse survival than those with less-vascularized cancers (P = 0.032). Cox multivariate analysis demonstrated that the most significant prognostic factors were presence of lymph node metastasis, tumor vascularization, COX-2 protein expression, and PgE(2) tumor levels. This study demonstrates a close correlation between COX-2 pathway, VEGF expression, and tumor angiogenesis in HNSCC. In addition, COX-2 overexpression and higher tumor vascularization appear to predict a shorter survival in patients with head and neck cancer. Copyright 2002, Elsevier Science (USA). All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12196922     DOI: 10.1053/hupa.2002.125376

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  60 in total

1.  Levels of prostaglandin E metabolite, the major urinary metabolite of prostaglandin E2, are increased in smokers.

Authors:  Neil D Gross; Jay O Boyle; Jason D Morrow; Myles K Williams; Chaya S Moskowitz; Kotha Subbaramaiah; Andrew J Dannenberg; Anna J Duffield-Lillico
Journal:  Clin Cancer Res       Date:  2005-08-15       Impact factor: 12.531

Review 2.  Molecular predictors of clinical outcome in patients with head and neck squamous cell carcinoma.

Authors:  Giovana R Thomas; Hari Nadiminti; Jacinto Regalado
Journal:  Int J Exp Pathol       Date:  2005-12       Impact factor: 1.925

3.  Cyclooxygenase-2 expression determines neo-angiogenesis in gallbladder carcinomas.

Authors:  Mateja Legan; Bostjan Luzar; Vera Ferlan-Marolt; Andrej Cör
Journal:  Bosn J Basic Med Sci       Date:  2006-11       Impact factor: 3.363

4.  Docetaxel and irinotecan in recurrent or metastatic head and neck cancer: a phase 2 trial of the Eastern Cooperative Oncology Group.

Authors:  Athanassios Argiris; Ashley Buchanan; Bruce Brockstein; Jill Kolesar; Musie Ghebremichael; Michael Pins; Kristine Hahn; Rita Axelrod; Arlene Forastiere
Journal:  Cancer       Date:  2009-10-01       Impact factor: 6.860

5.  Prognostic significance of VEGF immunohistochemical expression and tumor angiogenesis in head and neck squamous cell carcinoma.

Authors:  Panayiotis A Kyzas; Dimitrios Stefanou; Anna Batistatou; Niki J Agnantis
Journal:  J Cancer Res Clin Oncol       Date:  2005-10-20       Impact factor: 4.553

6.  Expression of cyclooxygenase (COX)-2 as a prognostic factor in nasopharyngeal cancer.

Authors:  Kyubo Kim; Hong-Gyun Wu; Suk Won Park; Chong Jai Kim; Charn Il Park
Journal:  Cancer Res Treat       Date:  2004-06-30       Impact factor: 4.679

7.  Tumor cyclooxygenase-2 levels correlate with tumor invasiveness in human hepatocellular carcinoma.

Authors:  Terence-C Tang; Ronnie-T Poon; Cecilia-P Lau; Dan Xie; Sheung-Tat Fan
Journal:  World J Gastroenterol       Date:  2005-04-07       Impact factor: 5.742

8.  Down-regulation of nitric oxide synthase-2 and cyclooxygenase-2 pathways by p53 in squamous cell carcinoma.

Authors:  Oreste Gallo; Nicola Schiavone; Laura Papucci; Iacopo Sardi; Lucia Magnelli; Alessandro Franchi; Emanuela Masini; Sergio Capaccioli
Journal:  Am J Pathol       Date:  2003-08       Impact factor: 4.307

9.  Elevated levels of urinary prostaglandin e metabolite indicate a poor prognosis in ever smoker head and neck squamous cell carcinoma patients.

Authors:  Vikram D Kekatpure; Jay O Boyle; Xi Kathy Zhou; Anna J Duffield-Lillico; Neil D Gross; Nancy Y Lee; Kotha Subbaramaiah; Jason D Morrow; Ginger Milne; Scott M Lippman; Andrew J Dannenberg
Journal:  Cancer Prev Res (Phila)       Date:  2009-10-20

10.  Prognostic Significance and Clinicopathological Associations of COX-2 SNP in Patients with Nonsmall Cell Lung Cancer.

Authors:  Peter P Grimminger; Jan Stöhlmacher; Daniel Vallböhmer; Paul M Schneider; Arnulf H Hölscher; Ralf Metzger; Peter V Danenberg; Jan Brabender
Journal:  J Oncol       Date:  2009-11-22       Impact factor: 4.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.